English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Press release submission | Jun 1, 2019

NATIONAL COMPREHENSIVE CANCER NETWORK: NCCN and AstraZeneca Support Quality Improvements for Lung Cancer Care

+ Community
Press release submission | May 31, 2019

CANCERCARE: Publishes New Manifesto Declaring the Importance of Patients' Values in Treatment Decision Making

+ Technology/Innovation
Press release submission | May 24, 2019

B DOT MEDICAL INC.: B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System

+ Community
Press release submission | May 24, 2019

EPILEPSY FOUNDATION: Awards $200,000 in Grants to Support Development of Innovative Products for Epilepsy Diagnosis & Treatment

+ Technology/Innovation
Press release submission | May 17, 2019

ALLERGAN PLC: Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis

+ Community
Press release submission | May 17, 2019

NORTHWESTERN MEMORIAL HOSPITAL: Annual Minds Matter Benefit Dinner Raises Funds for Northwestern Medicine Brain Tumor Patients

+ Technology/Innovation
Press release submission | May 10, 2019

EISAI INC.: Lower Hospitalization Rates In Epilepsy Patients Treated With Adjunctive FYCOMPA® (perampanel) CIII

+ Technology/Innovation
Press release submission | May 9, 2019

HOSPITAL FOR SPECIAL SURGERY: HSS Researchers Advance Understandings of the Cellular Mechanisms Driving Rheumatoid Arthritis

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 339
  • 340
  • 341
  • 342
  • 343
  • 344
  • 345
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily